245 related articles for article (PubMed ID: 25517815)
1. 'I'm fed up': experiences of prior anti-tuberculosis treatment in patients with drug-resistant tuberculosis and HIV.
Furin J; Isaakidis P; Reid AJ; Kielmann K
Int J Tuberc Lung Dis; 2014 Dec; 18(12):1479-84. PubMed ID: 25517815
[TBL] [Abstract][Full Text] [Related]
2. 'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis.
Isaakidis P; Rangan S; Pradhan A; Ladomirska J; Reid T; Kielmann K
Trop Med Int Health; 2013 Sep; 18(9):1128-1133. PubMed ID: 23837468
[TBL] [Abstract][Full Text] [Related]
3. Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.
van den Hof S; Tursynbayeva A; Abildaev T; Adenov M; Pak S; Bekembayeva G; Ismailov S
Int J Tuberc Lung Dis; 2013 Apr; 17(4):526-31. PubMed ID: 23485387
[TBL] [Abstract][Full Text] [Related]
4. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
[TBL] [Abstract][Full Text] [Related]
5. Results of rapid and successful integration of HIV diagnosis and care into tuberculosis services in Benin.
Ferroussier O; Dlodlo RA; Capo-Chichi D; Boillot F; Gninafon M; Trébucq A; Fujiwara PI
Int J Tuberc Lung Dis; 2013 Nov; 17(11):1405-10. PubMed ID: 24125442
[TBL] [Abstract][Full Text] [Related]
6. Tuberculosis in a cohort of HIV-positive patients: epidemiology, clinical practice and treatment outcomes.
Monge S; Diez M; Pulido F; Iribarren JA; Campins AA; Arazo P; Montero M; Miro JM; Moreno S; Del Amo J;
Int J Tuberc Lung Dis; 2014 Jun; 18(6):700-8. PubMed ID: 24903942
[TBL] [Abstract][Full Text] [Related]
7. Integrated, home-based treatment for MDR-TB and HIV in rural South Africa: an alternate model of care.
Brust JC; Shah NS; Scott M; Chaiyachati K; Lygizos M; van der Merwe TL; Bamber S; Radebe Z; Loveday M; Moll AP; Margot B; Lalloo UG; Friedland GH; Gandhi NR
Int J Tuberc Lung Dis; 2012 Aug; 16(8):998-1004. PubMed ID: 22668560
[TBL] [Abstract][Full Text] [Related]
8. HIV-positive patients treated for multidrug-resistant tuberculosis: clinical outcomes in the HAART era.
Palacios E; Franke M; Muñoz M; Hurtado R; Dallman R; Chalco K; Guerra D; Mestanza L; Llaro K; Bonilla C; Sebastian J; Bayona J; Lygizos M; Anger H; Shin S
Int J Tuberc Lung Dis; 2012; 16(3):348-54. PubMed ID: 22640448
[TBL] [Abstract][Full Text] [Related]
9. Community-based treatment of drug-resistant tuberculosis in Khayelitsha, South Africa.
Cox H; Hughes J; Daniels J; Azevedo V; McDermid C; Poolman M; Boulle A; Goemaere E; van Cutsem G
Int J Tuberc Lung Dis; 2014 Apr; 18(4):441-8. PubMed ID: 24670700
[TBL] [Abstract][Full Text] [Related]
10. Multidrug-resistant tuberculosis in an HIV-infected girl.
Shah I; Mohanty S
Natl Med J India; 2012; 25(4):210-1. PubMed ID: 23278778
[TBL] [Abstract][Full Text] [Related]
11. Undertreated HIV and drug-resistant tuberculosis at a referral hospital in Irkutsk, Siberia.
Heysell SK; Ogarkov OB; Zhdanova S; Zorkaltseva E; Shugaeva S; Gratz J; Vitko S; Savilov ED; Koshcheyev ME; Houpt ER
Int J Tuberc Lung Dis; 2016 Feb; 20(2):187-92. PubMed ID: 26792470
[TBL] [Abstract][Full Text] [Related]
12. Adverse events among HIV/MDR-TB co-infected patients receiving antiretroviral and second line anti-TB treatment in Mumbai, India.
Isaakidis P; Varghese B; Mansoor H; Cox HS; Ladomirska J; Saranchuk P; Da Silva E; Khan S; Paryani R; Udwadia Z; Migliori GB; Sotgiu G; Reid T
PLoS One; 2012; 7(7):e40781. PubMed ID: 22792406
[TBL] [Abstract][Full Text] [Related]
13. Microbiological investigation for tuberculosis among HIV-infected children in Soweto, South Africa.
Fairlie L; Muchiri E; Beylis CN; Meyers T; Moultrie H
Int J Tuberc Lung Dis; 2014 Jun; 18(6):676-81. PubMed ID: 24903938
[TBL] [Abstract][Full Text] [Related]
14. Effects of Ecuador's national monetary incentive program on adherence to treatment for drug-resistant tuberculosis.
Sripad A; Castedo J; Danford N; Zaha R; Freile C
Int J Tuberc Lung Dis; 2014 Jan; 18(1):44-8. PubMed ID: 24365551
[TBL] [Abstract][Full Text] [Related]
15. 'They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan.
Stringer B; Lowton K; Tillashaikhov M; Parpieva N; Ulmasova D; du Cros P; Hasker E; Sergeeva N
Int J Tuberc Lung Dis; 2016 Aug; 20(8):1084-90. PubMed ID: 27393544
[TBL] [Abstract][Full Text] [Related]
16. Revised Category II regimen as an alternative strategy for retreatment of Category I regimen failure and irregular treatment cases.
Tabarsi P; Chitsaz E; Tabatabaei V; Baghaei P; Shamaei M; Farnia P; Marjani M; Kazempour M; Mansouri D; Masjedi MR; Velayati AA
Am J Ther; 2011 Sep; 18(5):343-9. PubMed ID: 20535008
[TBL] [Abstract][Full Text] [Related]
17. Drug-resistant tuberculosis in Israel: risk factors and treatment outcomes.
Mor Z; Goldblatt D; Kaidar-Shwartz H; Cedar N; Rorman E; Chemtob D
Int J Tuberc Lung Dis; 2014 Oct; 18(10):1195-201. PubMed ID: 25216833
[TBL] [Abstract][Full Text] [Related]
18. Linezolid-containing regimens for the treatment of drug-resistant tuberculosis in South African children.
Rose PC; Hallbauer UM; Seddon JA; Hesseling AC; Schaaf HS
Int J Tuberc Lung Dis; 2012 Dec; 16(12):1588-93. PubMed ID: 23032215
[TBL] [Abstract][Full Text] [Related]
19. Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.
McNally TW; de Wildt G; Meza G; Wiskin CMD
BMC Health Serv Res; 2019 Aug; 19(1):594. PubMed ID: 31438958
[TBL] [Abstract][Full Text] [Related]
20. Are we justified in treating for multidrug-resistant tuberculosis based on positive follow-up smear results?
Kumar RS; Kumar AM; Claassens M; Banurekha VV; Sekar G; Venkatesan P; Swaminathan S
Int J Tuberc Lung Dis; 2014 Apr; 18(4):449-53. PubMed ID: 24670701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
